Impact of Gastric Banding Versus Metformin on β-Cell Function in Adults With Impaired Glucose Tolerance or Mild Type 2 Diabetes

scientific article published on 03 October 2018

Impact of Gastric Banding Versus Metformin on β-Cell Function in Adults With Impaired Glucose Tolerance or Mild Type 2 Diabetes is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.2337/DC18-1662
P932PMC publication ID6245202
P698PubMed publication ID30282699

P50authorAnny H XiangQ55539304
P2093author name stringJun Wu
Xinhui Wang
Thomas A Buchanan
Krishna S Nayak
Elizabeth Beale
Namir Katkhouda
Ting Chow
Enrique Trigo
Cortney Montgomery
Fadi Hendee
Mayra Martinez
RISE Collaborators
RISE Consortium
P2860cites workReduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or MetforminQ22250892
Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose toleranceQ28186874
Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes StudyQ29615122
Restoring Insulin Secretion (RISE): design of studies of β-cell preservation in prediabetes and early type 2 diabetes across the life spanQ30572405
Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trialQ33425402
The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitusQ33853759
Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trialQ33999757
Role of insulin secretion and sensitivity in the evolution of type 2 diabetes in the diabetes prevention program: effects of lifestyle intervention and metforminQ34335548
Gastric bypass and banding equally improve insulin sensitivity and β cell functionQ36439877
Oral disposition index predicts the development of future diabetes above and beyond fasting and 2-h glucose levelsQ37067149
Review of methods for measuring β-cell function: Design considerations from the Restoring Insulin Secretion (RISE) ConsortiumQ39298394
Low-dose combination therapy with rosiglitazone and metformin to prevent type 2 diabetes mellitus (CANOE trial): a double-blind randomised controlled studyQ42982910
(How) can we prevent type 2 diabetes?Q43834090
Health outcomes of severely obese type 2 diabetic subjects 1 year after laparoscopic adjustable gastric bandingQ43869418
Preservation of pancreatic beta-cell function and prevention of type 2 diabetes by pharmacological treatment of insulin resistance in high-risk hispanic womenQ44114894
Improvements in insulin sensitivity and beta-cell function (HOMA) with weight loss in the severely obese. Homeostatic model assessmentQ44311724
beta-Cell function in subjects spanning the range from normal glucose tolerance to overt diabetes: a new analysisQ45105931
Coordinate changes in plasma glucose and pancreatic beta-cell function in Latino women at high risk for type 2 diabetesQ46326007
The Indian Diabetes Prevention Programme shows that lifestyle modification and metformin prevent type 2 diabetes in Asian Indian subjects with impaired glucose tolerance (IDPP-1).Q46878587
Glucose Metabolism After Gastric Banding and Gastric Bypass in Individuals With Type 2 Diabetes: Weight Loss EffectQ47249342
A 2-year Trial of Intermittent Insulin Therapy versus Metformin for the Preservation of Beta-cell Function after Initial Short-term Intensive Insulin Induction in early Type 2 Diabetes.Q48151386
Metformin and β-cell function in insulin-treated patients with type 2 diabetes: A randomized placebo-controlled 4.3-year trial.Q48261738
Pioglitazone for diabetes prevention in impaired glucose tolerance.Q51161029
Metabolic Contrasts Between Youth and Adults With Impaired Glucose Tolerance or Recently Diagnosed Type 2 Diabetes: I. Observations Using the Hyperglycemic ClampQ89239973
Metabolic Contrasts Between Youth and Adults With Impaired Glucose Tolerance or Recently Diagnosed Type 2 Diabetes: II. Observations Using the Oral Glucose Tolerance TestQ89239976
Impact of Insulin and Metformin Versus Metformin Alone on β-Cell Function in Youth With Impaired Glucose Tolerance or Recently Diagnosed Type 2 DiabetesQ89239984
P433issue12
P407language of work or nameEnglishQ1860
P921main subjectmetforminQ19484
glucoseQ37525
type 2 diabetesQ3025883
P304page(s)2544-2551
P577publication date2018-10-03
P1433published inDiabetes CareQ5270111
P1476titleImpact of Gastric Banding Versus Metformin on β-Cell Function in Adults With Impaired Glucose Tolerance or Mild Type 2 Diabetes
P478volume41

Reverse relations

cites work (P2860)
Q92970677Long-Term Effects of a Novel Continuous Remote Care Intervention Including Nutritional Ketosis for the Management of Type 2 Diabetes: A 2-Year Non-randomized Clinical Trial
Q90798037Phase 1 dose-finding study of metformin in combination with concurrent cisplatin and radiotherapy in patients with locally advanced head and neck squamous cell cancer
Q92795184Reversing Type 2 Diabetes: A Narrative Review of the Evidence

Search more.